Skip to main content

Table 2 Postoperative IOP (mmHg) in the surgical groups. Mean (±SD; 95%CI); % change in IOP from baseline

From: Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up

 

MMC group

OLO group

P a

3rd month

14.7(3.9; 12.9-16.4)

15.0(3.8; 13.3-16.7)

0.806

44.5 %

45.1 %

6th month

14.7(4.3; 12.7-16.6)

14.1(3.1; 12.6-15.4)

0.615

44.5 %

48.4 %

12th month

15.0(3.0; 13.6-16.4)

15.2(2.8; 13.8-16.4)

0.828

43.4 %

44.3 %

24th month

16.0(2.9; 14.6-17.4)

16.5(2.1; 15.5-17.4)

0.536

39.6 %

39.5 %

36th month

15.6 (2.6; 14.3-16.9)

15.9 (2.5; 14.6-17.2)

0.706

39.8 %

40.2 %

48th month

15.9 (2.6; 14.5-17.2)

15.3 (3.4; 13.4-17.1)

0.563

38.8 %

42.3 %

60th month

15.2 (3.2; 13.4-16.9)

15.8 (±2.3; 14.4-17.1)

0.579

41.0 %

42.1 %

  1. a Independent Student t test; MMC = Mitomycin-C; OLO = Ologen; SD = standard deviation